FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940693857> ?p ?o ?g. }

• W2940693857 endingPage "2375" @default.
• W2940693857 startingPage "2364" @default.
• W2940693857 abstract "This study focused on formulating conjugate vaccines targeting oxycodone and heroin for technology transfer, good manufacturing practice (GMP), and clinical evaluation. Lead vaccines used the highly immunogenic carrier protein keyhole limpet hemocyanin (KLH), which poses formulation problems because of its size. To address this barrier to translation, an oxycodone-based hapten conjugated to GMP-grade subunit KLH (OXY-sKLH) and adsorbed on alum adjuvant was studied with regard to carbodiimide coupling reaction time, buffer composition, purification methods for conjugates, conjugate size, state of aggregation, and protein/alum ratio. Vaccine formulations were screened for post-immunization antibody levels and efficacy in reducing oxycodone distribution to the brain in rats. While larger conjugates were more immunogenic, their size prevented characterization of the haptenation ratio by standard analytical methods and sterilization by filtration. To address this issue, conjugation chemistry and vaccine formulation were optimized for maximal efficacy, and conjugate size was measured by dynamic light scattering prior to adsorption to alum. An analogous heroin vaccine (M-sKLH) was also optimized for conjugation chemistry, formulated in alum, and characterized for potency against heroin in rats. Finally, this study found that the efficacy of OXY-sKLH was preserved when co-administered with M-sKLH, supporting the proof of concept for a bivalent vaccine formulation targeting both heroin and oxycodone. This study suggests methods for addressing the unique formulation and characterization challenges posed by conjugating small molecules to sKLH while preserving vaccine efficacy." @default.
• W2940693857 created "2019-05-03" @default.
• W2940693857 creator A5003368399 @default.
• W2940693857 creator A5004598118 @default.
• W2940693857 creator A5011990703 @default.
• W2940693857 creator A5019893864 @default.
• W2940693857 creator A5021645428 @default.
• W2940693857 creator A5024624450 @default.
• W2940693857 creator A5047686095 @default.
• W2940693857 creator A5048775903 @default.
• W2940693857 creator A5071953967 @default.
• W2940693857 creator A5079256056 @default.
• W2940693857 creator A5087801455 @default.
• W2940693857 date "2019-04-24" @default.
• W2940693857 modified "2023-09-23" @default.
• W2940693857 title "Formulation and Characterization of Conjugate Vaccines to Reduce Opioid Use Disorders Suitable for Pharmaceutical Manufacturing and Clinical Evaluation" @default.
• W2940693857 cites W1507931707 @default.
• W2940693857 cites W1511341274 @default.
• W2940693857 cites W1926794439 @default.
• W2940693857 cites W1964269606 @default.
• W2940693857 cites W1973555453 @default.
• W2940693857 cites W1980714794 @default.
• W2940693857 cites W1991529485 @default.
• W2940693857 cites W1995390358 @default.
• W2940693857 cites W2001678152 @default.
• W2940693857 cites W2013543590 @default.
• W2940693857 cites W2016313703 @default.
• W2940693857 cites W2045900882 @default.
• W2940693857 cites W2046182783 @default.
• W2940693857 cites W2048049691 @default.
• W2940693857 cites W2058120775 @default.
• W2940693857 cites W2062645946 @default.
• W2940693857 cites W2069871552 @default.
• W2940693857 cites W2095786607 @default.
• W2940693857 cites W2104187422 @default.
• W2940693857 cites W2109611492 @default.
• W2940693857 cites W2111778824 @default.
• W2940693857 cites W2118084077 @default.
• W2940693857 cites W2130197019 @default.
• W2940693857 cites W2131660678 @default.
• W2940693857 cites W2157786910 @default.
• W2940693857 cites W2165614931 @default.
• W2940693857 cites W2165697122 @default.
• W2940693857 cites W2166436925 @default.
• W2940693857 cites W2287629567 @default.
• W2940693857 cites W2336703294 @default.
• W2940693857 cites W2487584944 @default.
• W2940693857 cites W2553772214 @default.
• W2940693857 cites W2561135550 @default.
• W2940693857 cites W2616124434 @default.
• W2940693857 cites W2621173434 @default.
• W2940693857 cites W2760237777 @default.
• W2940693857 cites W2773895504 @default.
• W2940693857 cites W2774917151 @default.
• W2940693857 cites W2793566209 @default.
• W2940693857 cites W2794764561 @default.
• W2940693857 cites W2807164387 @default.
• W2940693857 cites W2889961731 @default.
• W2940693857 doi "https://doi.org/10.1021/acs.molpharmaceut.8b01296" @default.
• W2940693857 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6598681" @default.
• W2940693857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31018096" @default.
• W2940693857 hasPublicationYear "2019" @default.
• W2940693857 type Work @default.
• W2940693857 sameAs 2940693857 @default.
• W2940693857 citedByCount "13" @default.
• W2940693857 countsByYear W29406938572019 @default.
• W2940693857 countsByYear W29406938572020 @default.
• W2940693857 countsByYear W29406938572021 @default.
• W2940693857 countsByYear W29406938572022 @default.
• W2940693857 countsByYear W29406938572023 @default.
• W2940693857 crossrefType "journal-article" @default.
• W2940693857 hasAuthorship W2940693857A5003368399 @default.
• W2940693857 hasAuthorship W2940693857A5004598118 @default.
• W2940693857 hasAuthorship W2940693857A5011990703 @default.
• W2940693857 hasAuthorship W2940693857A5019893864 @default.
• W2940693857 hasAuthorship W2940693857A5021645428 @default.
• W2940693857 hasAuthorship W2940693857A5024624450 @default.
• W2940693857 hasAuthorship W2940693857A5047686095 @default.
• W2940693857 hasAuthorship W2940693857A5048775903 @default.
• W2940693857 hasAuthorship W2940693857A5071953967 @default.
• W2940693857 hasAuthorship W2940693857A5079256056 @default.
• W2940693857 hasAuthorship W2940693857A5087801455 @default.
• W2940693857 hasBestOaLocation W29406938572 @default.
• W2940693857 hasConcept C134306372 @default.
• W2940693857 hasConcept C159654299 @default.
• W2940693857 hasConcept C170493617 @default.
• W2940693857 hasConcept C178790620 @default.
• W2940693857 hasConcept C185592680 @default.
• W2940693857 hasConcept C197336794 @default.
• W2940693857 hasConcept C202751555 @default.
• W2940693857 hasConcept C203014093 @default.
• W2940693857 hasConcept C21951064 @default.
• W2940693857 hasConcept C2776029756 @default.
• W2940693857 hasConcept C2776727803 @default.
• W2940693857 hasConcept C2777863537 @default.
• W2940693857 hasConcept C2780868878 @default.
• W2940693857 hasConcept C2780924562 @default.
• W2940693857 hasConcept C2781063702 @default.

• next